Publication: Low compliance contribute to insufficient Desmopressin response of primary monosymptomatic nocturnal enuresis and the role of voiding school
| dc.contributor.author | Radojicic, Zoran (12768612400) | |
| dc.contributor.author | Milivojevic, Sasa (57202783337) | |
| dc.contributor.author | Koricanac, Irena (57209261029) | |
| dc.contributor.author | Lazovic, Jelena Milin (57023980700) | |
| dc.contributor.author | Laketic, Darko (25936376800) | |
| dc.contributor.author | Radojicic, Ognjen (57223969149) | |
| dc.contributor.author | Milic, Natasa (7003460927) | |
| dc.date.accessioned | 2025-06-12T13:09:36Z | |
| dc.date.available | 2025-06-12T13:09:36Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | Aims: To evaluate the impact of compliance on the therapeutic effects of Desmopressin, as well as the importance of establishing the voiding school for low-compliance children in primary monosymptomatic enuresis treatment. Methods: Eighty-nine patients with primary monosymptomatic enuresis treated with Desmopressin were observed during the 2017–2020 at University Children’s Hospital Belgrade, Serbia. The average patients age was 7.7 ± 2.4 years; 65 (73%) were boys and 24 (27%) % were girls. After the 3 months of Desmopressin treatment, the effect of therapy was evaluated according to the compliance. After the treatment, low-compliance patients and their parents were suggested to visit a voiding school. Results: A significant decrease in the median enuresis frequency was noticed during the Desmopressin treatment (25.0 (20.0–26.0) vs 10.0 (2.0–17.0) per month, before vs after treatment, respectively) (p < 0.001). Patients with low compliance had a poorer response to Desmopressin (p < 0.001). An median enuresis reduction in the good compliance group was 92.3% (86.7 -95%), while in the low compliance group was 28.6% (16.7–43.3%). After attending voiding school, there was a significant increase in compliance (p < 0.001), associated with an median percent decrease in enuresis of 84.0% (75.0–95.5%) (p < 0.001). Conclusion: Compliance considerably influences the beneficial effects of Desmopressin. Patients with poor therapeutic effects should be evaluated for compliance and introduced to voiding school. © 2021, The Author(s). | |
| dc.identifier.uri | https://doi.org/10.1186/s12887-021-02714-z | |
| dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85106653946&doi=10.1186%2fs12887-021-02714-z&partnerID=40&md5=dc40f2dbcbd11d8d750c1d1d18fa9539 | |
| dc.identifier.uri | https://remedy.med.bg.ac.rs/handle/123456789/3872 | |
| dc.subject | Children | |
| dc.subject | Compliance | |
| dc.subject | Desmopressin | |
| dc.subject | Primary Monosymptomatic nocturnal enuresis | |
| dc.subject | Voiding school | |
| dc.title | Low compliance contribute to insufficient Desmopressin response of primary monosymptomatic nocturnal enuresis and the role of voiding school | |
| dspace.entity.type | Publication |
